Article
The influence of CYP3A5*3 and BCRPC421A genetic polymorphisms on the pharmacokinetics of felodipine in healthy Chinese volunteers.
Journal of clinical pharmacy and therapeutics - 1 Jun 2017
Xiang Q, Li C, Zhao X, Cui Y M
Abstract excerpt
WHAT IS KNOWN AND OBJECTIVE: The role of CYP3A5 in drug metabolism has been receiving attention because CYP3A5 may be more involved in the metabolism of CYP3A substrates in vivo than previously thought. The polymorphism of transporters, such as P-gp (P-glycoprotein) and breast cancer-related protein (BCRP), influences the metabolism of these substrates, and felodipine is a substrate of P-gp. The aim of this study...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
